Trillium Therapeutics Announces Proposed Public Offering of Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- McKesson reports cybersecurity incident affecting its information systems
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Ovintiv adds 41,000 acres in Permian and Montney deals
UPDATE: Trillium Therapeutics (TRIL) Prices 1.52M Common Offering at $19.50/Share
April 1, 2015 7:01 AM EDT(Updated - April 1, 2015 7:03 AM EDT)
Trillium Therapeutics (NASDAQ: TRIL) has priced a 1.52 million common stock offering at $19.50 per share.
UPDATE - The press release and SEC filing follow:
Trillium Therapeutics announced that it has priced an underwritten public offering of 1,522,395 common... More
Trillium Therapeutics (TRIL) Announces $50M Common Stock Offering
March 30, 2015 4:03 PM EDTTrillium Therapeutics (NASDAQ: TRIL) announced that it is offering to sell US$50,000,000 of common shares and preferred shares in an underwritten public offering. The preferred shares are being offered to certain of Trillium's existing shareholders whose purchase of common shares in this offering may... More
